Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €73.05 | 6.638% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.44 | €38.19 | 96.469% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.90 | €20.43 | 71.702% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €7.22 | €11.00 | 52.397% |
| Chemed Corp. | 5 | 0 | 1 | 0 | €535.00 | €588.14 | 9.933% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.26 | €19.86 | 217.331% |
| Dexcom Inc. | 18 | 0 | 1 | 0 | €117.92 | €136.82 | 16.030% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.75 | €8.75 | 12.903% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €362.30 | €421.61 | 16.369% |
| Merit Medical Systems | 17 | 0 | 5 | 0 | €72.50 | €86.90 | 19.858% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Personalis Inc | 7 | 0 | 2 | 0 | €1.50 | €3.25 | 117.275% |
| Amn Healthcare Svs | 1 | 0 | 1 | 0 | €55.50 | - | - |
| XOMA Corp. | 6 | 0 | 3 | 0 | €22.20 | €68.78 | 209.817% |
| Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | €261.90 | €445.58 | 70.135% |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €109.00 | €116.99 | 7.332% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| United Therapeutics | 18 | 0 | 3 | 0 | €245.40 | €288.66 | 17.629% |
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| aTyr Pharma Inc | 2 | 0 | 1 | 0 | €1.57 | €10.00 | 536.943% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.00 | €47.53 | 76.030% |
| Humana Inc. | 23 | 0 | 3 | 0 | €311.60 | €439.88 | 41.167% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |